BACKGROUND: The efficacy of smoking cessation interventions for hospital patients has been well described, but we know little regarding implementation and outcomes of real-world programs. OBJECTIVE: To describe the services provided and outcomes of an academic medical center-based tobacco treatment service (UKanQuit) located in the Midwestern United States. METHOD: This is a descriptive observational study. Both quantitative and qualitative data of all patients treated by UKanQuit over a 1-year period were analyzed. RESULTS: Among 513 patients served, average interest in quitting was 7.9, standard deviation (SD) 2.9 on a scale of 0 to 10. More than 1 in 4 had been given an in-hospital medication to ameliorate withdrawal prior to seeing a counselor. Counselors recommended medication changes for 1 in 3 patients, helped 73% set a goal for quitting or reducing tobacco use, and fax referred 56% to quitlines. Six-month follow-up (response rate, 46%) found a 7-day abstinence rate of 32% among respondents for an intent-to-treat abstinence rate of 15%. Post-discharge, 74% made at least one serious quit attempt, 34% had used a quit smoking medication, but only 5% of those referred to the quitline reported using it. CONCLUSIONS: In a hospital setting, interest in quitting is high among smokers who requested to see a tobacco counselor but administration of inpatient medications remains low. Many smokers are making unassisted quit attempts post-discharge because utilization of cessation medications and quitline counseling were low. Fax-referral to quitline may not, on its own, fulfill guideline recommendations for post-discharge follow-up.
BACKGROUND: The efficacy of smoking cessation interventions for hospital patients has been well described, but we know little regarding implementation and outcomes of real-world programs. OBJECTIVE: To describe the services provided and outcomes of an academic medical center-based tobacco treatment service (UKanQuit) located in the Midwestern United States. METHOD: This is a descriptive observational study. Both quantitative and qualitative data of all patients treated by UKanQuit over a 1-year period were analyzed. RESULTS: Among 513 patients served, average interest in quitting was 7.9, standard deviation (SD) 2.9 on a scale of 0 to 10. More than 1 in 4 had been given an in-hospital medication to ameliorate withdrawal prior to seeing a counselor. Counselors recommended medication changes for 1 in 3 patients, helped 73% set a goal for quitting or reducing tobacco use, and fax referred 56% to quitlines. Six-month follow-up (response rate, 46%) found a 7-day abstinence rate of 32% among respondents for an intent-to-treat abstinence rate of 15%. Post-discharge, 74% made at least one serious quit attempt, 34% had used a quit smoking medication, but only 5% of those referred to the quitline reported using it. CONCLUSIONS: In a hospital setting, interest in quitting is high among smokers who requested to see a tobacco counselor but administration of inpatient medications remains low. Many smokers are making unassisted quit attempts post-discharge because utilization of cessation medications and quitline counseling were low. Fax-referral to quitline may not, on its own, fulfill guideline recommendations for post-discharge follow-up.
Authors: C Barr Taylor; Nancy Houston Miller; Rebecca P Cameron; Emily Wien Fagans; Smita Das Journal: Nicotine Tob Res Date: 2005-02 Impact factor: 4.244
Authors: Charles J Bentz; K Bruce Bayley; Kerry E Bonin; Lori Fleming; Jack F Hollis; Timothy McAfee Journal: Am J Prev Med Date: 2006-01 Impact factor: 5.043
Authors: Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Kimber P Richter; Babalola Faseru; Theresa I Shireman; Laura M Mussulman; Niaman Nazir; Terry Bush; Taneisha S Scheuermann; Kristopher J Preacher; Beatriz H Carlini; Brooke Magnusson; Edward F Ellerbeck; Carol Cramer; David J Cook; Mary J Martell Journal: Am J Prev Med Date: 2016-10 Impact factor: 5.043
Authors: Susan Regan; Michele Reyen; Ann E Richards; Abigail C Lockhart; Aliza K Liebman; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2011-11-25 Impact factor: 4.244
Authors: Sharon A Fitzgerald; Kimber P Richter; Laura Mussulman; Eric Howser; Shadi Nahvi; Kathy Goggin; Nina A Cooperman; Babalola Faseru Journal: Jt Comm J Qual Patient Saf Date: 2016-05
Authors: A Benjamin Srivastava; Alex T Ramsey; Leslie D McIntosh; Thomas C Bailey; Sherri L Fisher; Louis Fox; Mario Castro; Yinjiao Ma; Timothy B Baker; Li-Shiun Chen; Laura J Bierut Journal: Nicotine Tob Res Date: 2019-04-17 Impact factor: 4.244
Authors: Kimber P Richter; Babalola Faseru; Laura M Mussulman; Edward F Ellerbeck; Theresa I Shireman; Jamie J Hunt; Beatriz H Carlini; Kristopher J Preacher; Candace L Ayars; David J Cook Journal: Trials Date: 2012-08-01 Impact factor: 2.279
Authors: Sonia A Duffy; David L Ronis; Marita G Titler; Frederic C Blow; Neil Jordan; Patricia L Thomas; Gay L Landstrom; Lee A Ewing; Andrea H Waltje Journal: Trials Date: 2012-08-01 Impact factor: 2.279